|Mr. Jeffrey David Edwards||Founder, MD, Technical Director & Exec. Director||345.73k||N/A||N/A|
|Dr. Matthew McIldowie||Chief Scientific Officer||N/A||N/A||N/A|
|Mr. Paul Peros||Chief Exec. Officer of New Beauty Technology Division||N/A||N/A||N/A|
|Mr. John Joseph Palermo B.Bus, CA, FCA, ASCA, J.P., ACIS, AGIA, Snr||Company Sec.||N/A||N/A||N/A|
|Dr. Michael Roberts||Scientific Adviser||N/A||N/A||N/A|
OBJ Limited develops dermaportation and enhanced transdermal polymer technologies for use in the pharmaceutical, cosmetic and skincare, and consumer healthcare sectors in Australia. The company provides partnering services and product solutions for technologies in transdermal and intra-dermal drug delivery; therapeutic and dermatological skincare; cosmetic and non-medicinal active ingredient; oral health; haircare solutions utilizing enhanced brushes and applicators; high penetration surface hygiene technologies; fabric and carpet cleaning technologies; and industrial surface interface systems. It offers various technology platforms, such as Static Micro-arrays, a film based micro-array technology for patches, masks, dressings, and other topical applications; and Field in Motion Micro-arrays, a magnetic micro-array film for use in brushes, applicators, and wipes; Dermaportation, a product development platform for a range of commercial applications; eSkin, a multi-product delivery system that offers a range of product-specific, time-varying magnetic fields for enhanced delivery of multiple formulations; and measured dose delivery devices and packaging solutions. OBJ Limited was founded in 2004 and is based in Leederville, Australia.
OBJ Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.